<DOC>
	<DOCNO>NCT00933049</DOCNO>
	<brief_summary>The investigator hypothesize Oral amoxicillin ( 25mg/kg/dose bid ) give child age 2-59 month pneumonia , would lead good clinical outcome day three 89.9 % child compare 77.0 % child receive oral cotrimoxazole ( 8 mg/kg/dose trimethoprim , 40 mg/kg/dose sulphamethoxazole ) . A double blind randomize control trial conduct Assessment Center Mulago Hospital . Children non-severe pneumonia randomize receive either oral amoxicillin ( 25 mg/kg/dose ) cotrimoxazole ( trimethoprim 8 mg/kg sulphamethoxazole 40 mg/kg ) follow day 3 5 treatment . The primary outcome measure normalization respiratory rate day 3 treatment . Secondary outcome measure antimicrobial susceptibility cotrimoxazole amoxicillin .</brief_summary>
	<brief_title>Cotrimoxazole Versus Amoxicillin Treatment Community Acquired Pneumonia Children Aged 2-59 Months</brief_title>
	<detailed_description>A triage Nurse identify recorded child age 2- 59 month present history cough , difficult breathing , fast breathing ( tachypnea ) Assessment Center Mulago Hospital . Children age 2-11 month respiratory rate &gt; 50 breath per minute age 12-59 month respiratory rate &gt; 40 breath per minute enrol study follow informed consent parents/caretakers . Clinical history include patient 's detailed record illness , previous medical history antibiotic use current illness . The IMCI approach particularly employed history take examination . The Principle Investigator research assistant interview caretaker use structured questionnaire . 5 ml blood drawn ante cubital fossa complete blood count blood cultures.In addition thin thick blood smear malaria parasite take use finger prick blood sample . Rapid HIV antibody test do determine HIV serostatus child . Children le 18 month positive antibody test refer Paediatric Infectious Disease Clinic ( PIDC ) Mulago Hospital DNA-PCR test confirm HIV infection status . Study participant place well aerated room subject sputum induction . The principal investigator , help research assistant nurse perform procedure . The study patient nebulised salbutamol dose 0.1mg/kg 3ml Normal saline . 3mls 3 % sterile saline administer facemask nebuliser 10-15 minutes.Sputum obtain expectoration ( child could ) nasopharyngeal suction unable expectorate . Gram stain , ZN stain culture sensitivity perform sputum . Oxygen saturation measure sputum induction . For child oxygen saturation le 92 % could tolerate sputum induction , procedure defer follow day child stable . However , continue treatment . Treatment assignment conceal patient , parent , study personnel . Children assign co-trimoxazole receive active medicine ( 8 mg/kg/dose trimethoprim + 40 mg/kg/dose sulphamethoxazole ) amoxicillin placebo twice day . Children assign amoxicillin receive active medicine ( 25 mg/kg/dose ) co-trimoxazole placebo twice day.A randomization scheme develop use table random number generate computer . Study participant randomly assign treatment block 4 12 . Both drug placebo manufacture package volume 100mls color . Treatment start soon patient enrol study withdrawal blood sputum sample . Drug dose calculate accord body weight . Cotrimoxazole give orally ( syrup ) dose 8mg/kg/dose trimethoprim , 40mg/kg/dose sulphamethoxazole oral ( syrup ) amoxicillin dose 25mg/kg/dose every 12 hour total 5 day reach . The study two treatment arm ; one arm randomly assign receive active amoxicillin plus placebo cotrimoxazole orally arm randomly assign receive active cotrimoxazole placebo amoxicillin two dos per day . The study nurse principle investigator demonstrate parent/caretaker give study drug give first dose clinic . An explanation give give medication home level understand check leave clinic . Caretakers instruct give medication especially antibiotic give hospital instruct return clinic day 3 5 treatment . Paracetamol syrup administer febrile child dose 15 mg/kg 4 - 6 hourly axillary temperature 38.5 degree Celsius . Vitamin A give accord national recommendation guideline . Patients diagnose malaria blood slide give Arthemeter-Lumefantrine tablet . Other medication well give accord presentation diagnosis.The day enrollment count day 0 . After three day treatment , patient check general danger sign assess cough difficult breathe respiratory rate count . Improvement define slow respiratory rate ( either back normal range age , 5 breath per minute low compare previous evaluation ) , less fever , normal oxygen saturation well appetite , patient request complete 5 day antibiotics final follow day 5 treatment .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Children age 259 month non severe pneumonia base WHO criteria respiratory rate age specific cutoff Accessible follow Written inform consent parent/caretaker Children severe pneumonia Documented use antibiotic last 48 hour Confirmed HIV positive cotrimoxazole prophylaxis Three episodes wheeze year asthmatic attack History hospitalization within last 15 day Measles within last one month Previous history allergy cotrimoxazole amoxicillin</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Efficacy</keyword>
	<keyword>child</keyword>
	<keyword>pneumonia</keyword>
	<keyword>cotrimoxazole</keyword>
	<keyword>amoxicillin</keyword>
</DOC>